Singapore vs Slovenia: Access to anti-retroviral drugs, male
Singapore
86.0%
in 2023
Slovenia
87.0%
in 2024
Singapore rank
30th
Slovenia rank
27th
Access to anti-retroviral drugs, male over time
- Singapore
- Slovenia
How they compare
Slovenia currently reports 87.0% against 86.0% in Singapore, a difference of 1.0%.
The two have swapped places 7 times across 24 shared years of data; in 2000 it was Slovenia ahead.
Singapore ranks 30th and Slovenia ranks 27th of 141 countries.
Across the 3 decades both report, Singapore averaged higher in 1 and Slovenia in 2.
Head to head by decade
| Decade | Singapore | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 18.5% | 40.8% | 22.3% | Slovenia |
| 2010s | 71.2% | 72.8% | 1.6% | Slovenia |
| 2020s | 85.2% | 84.8% | 0.5% | Singapore |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Singapore or Slovenia?
- Slovenia, at 87.0% against 86.0% in Singapore as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Singapore and Slovenia?
- 1.0%, with Slovenia ahead.
- How many years of comparable data are there for Singapore and Slovenia?
- 24 years are reported by both, from 2000 to 2023.
- How do Singapore and Slovenia rank globally for access to anti-retroviral drugs, male?
- Singapore ranks 30th and Slovenia ranks 27th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.